Schedule 13G ownership disclosure

LAKEFRONT BIOTHERAPEUTICS NV

Security class unavailable · CUSIP: 36315X101

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,643,808
Percent of class
4.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001140361-20-003311
Form type
SC 13G/A
Filer
Lakefront Biotherapeutics NV
CIK
CIK 1421876
Filed
Feb 14, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub